Status:

COMPLETED

Reducing Internalized Stigma in People With Serious Mental Illness

Lead Sponsor:

VA Office of Research and Development

Conditions:

Schizophrenia

Schizoaffective Disorder

Eligibility:

All Genders

18-80 years

Phase:

PHASE2

Brief Summary

The purpose of this study is to determine if Ending Self-Stigma (ESS), a 9-session group intervention designed to assist veterans with serious mental illness to develop skills (SMI) to effectively cop...

Detailed Description

Background: Stigmatizing beliefs and attitudes about mental illness are prevalent and exposure to stigma is common among people with mental illness. The negative effects of stigma are compounded when...

Eligibility Criteria

Inclusion

  • Diagnosis of Schizophrenia
  • Schizoaffective disorder
  • Bipolar Disorder
  • or Major Depression with Psychotic Features
  • Age 18 to 80
  • Receiving services at one of VA Medical Center study sites
  • Ability and willingness to provide consent to participate
  • Agreement obtained from the treating clinician that the patient is clinically stable enough to participate in the study

Exclusion

  • Severe or profound mental retardation by chart review

Key Trial Info

Start Date :

October 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2015

Estimated Enrollment :

252 Patients enrolled

Trial Details

Trial ID

NCT01259427

Start Date

October 1 2011

End Date

September 1 2015

Last Update

March 8 2016

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Washington DC VA Medical Center, Washington, DC

Washington D.C., District of Columbia, United States, 20422

2

VA Maryland Health Care System, Baltimore

Baltimore, Maryland, United States, 21201

3

Perry Point VA Medical Center VA Maryland Health Care System, Perry Point, MD

Perry Point, Maryland, United States, 21902